FDA OKs test to ID blood-infection bacteria
The U.S. Food and Drug Administration (FDA) has approved the marketing of the first nucleic acid test that can identify 12 different bacterial types known to cause bloodstream infections. The test, created by Nanosphere, allows for simultaneous identification of the bacteria and three associated resistance genes in just a few hours after the first sign of bacterial growth. Traditional methods may require two to four days to produce bacterial identification

